NCT06822426

AUG 5, 2026 · PHASE 3 TRIAL

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

ClinicalTrials.gov

This is a Phase 3 RCT registration with no reported results; the study is actively recruiting and outcomes have not yet been published in this registry record.